LUCA TONDULLI

Head of Medical Oncology

Provincia autonoma di Bolzano - Alto Adige

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Luca Tondulli is the Head of Medical Oncology at Provincia autonoma di Bolzano - Alto Adige, Italy. His research areas focus on the effectiveness and toxicity of immunotherapies for various cancers, including advanced cutaneous squamous cell carcinoma and head and neck cancers. Additionally, he examines the impact of nutritional support on immune functions in cancer patients and has investigated the implications of the COVID-19 pandemic on oncological practices.

Articles (7)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Lisa Licitra

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Salvatore Alfieri

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Claudio Luchini

Associate Professor of Pathology

University of Verona

ITALY

View details

Caterina Soldà

Istituto Oncologico Veneto

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

LUCA TONDULLI

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Real‐world multicentre observational study of effectiveness and toxicity in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy

ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma

Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))

Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.

Influence of different lipid emulsions on specific immune cell functions in head and neck cancer patients receiving supplemental parenteral nutrition: An exploratory analysis

Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.

Collaborators (4)

Lisa Licitra

Salvatore Alfieri

Claudio Luchini

Caterina Soldà

Make your next move.